Skip to main content
SERA PROGNOSTICS, INC. logo

SERA PROGNOSTICS, INC. — Investor Relations & Filings

Ticker · SERA ISIN · US81749D1072 US Manufacturing
Filings indexed 558 across all filing types
Latest filing 2024-11-06 Interim / Quarterly Rep…
Country US United States of America
Listing US SERA

About SERA PROGNOSTICS, INC.

https://www.sera.com/

Sera Prognostics, Inc., also known as 'The Pregnancy Company®', is a health diagnostics company focused on improving maternal and infant health through precision pregnancy care. The company's flagship product is the PreTRM® Test, a first-of-its-kind biomarker blood test designed to predict the individual risk of spontaneous preterm birth in asymptomatic women with singleton pregnancies. The test is administered via a single blood draw during the 18th to 20th week of gestation, providing pivotal information to physicians for proactive management. Sera Prognostics also offers the LikeMine™ platform, which uses data from millions of pregnancies to offer comparative insights. The company aims to deliver high-value diagnostics to providers, mothers, payers, and employers to improve health outcomes and reduce healthcare costs associated with premature birth.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q3 2024
2024-11-06 English
8-K
Regulatory Filings
2024-11-06 English
SC 13G/A
Major Shareholding Notification
2024-11-04 English
Regulatory Filings 2024
Regulatory Filings
2024-10-08 English
4
Director's Dealing
2024-10-08 English
Regulatory Filings 2024
Regulatory Filings
2024-09-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.